Truist Securities Reiterates Buy Rating on Solid Biosciences (SLDB): "we are buyers of the selloff"
Tweet Send to a Friend
Truist Securities analyst Joon Lee reiterated a Buy rating and $16.00 price target on Solid Biosciences (NASDAQ: SLDB)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
